MedTrace Logo

Diurnal Variation in Tear Osmolarity

NCT01321424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-04-25

No results posted yet for this study

Summary

The purpose of this study is to measure the change in Tear Osmolarity during the course of the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and differentiate between the two forms of dry eye.

Conditions

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Ophthalmic Consultants of Long Island

    lead OTHER

Principal Investigators

  • Eric D Donnenfeld, MD · Ophthalmic Consultants of Long Island

  • Barbara Burger, RN · Ophthalmic Consultants of Long Island

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2016-02-29
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321424 on ClinicalTrials.gov